The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
Treatment with β-blockers is the main strategy for managing patients with heart failure and reduced ejection fraction because of their ability to reverse the neurohumoral effects of the sympathetic nervous system, with consequent prognostic and symptomatic benefits. However, to date, they are underu...
Saved in:
Published in | Journal of cardiovascular development and disease Vol. 8; no. 9; p. 101 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
24.08.2021
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!